NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today
that the U.S. Food and Drug Administration (FDA) has cleared its System One™
to perform hemodialysis overnight while the patient is...
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. TheStreet Ratings quantitative algorithm...
Medical device maker NxStage filters out the pessimists and rockets higher by as much as 13% after reporting better-than-expected third-quarter earnings results and lifting its full-year sales forecast.
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to NxStage Medical (NXTM):